[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370177-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370177-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","investigating-papillary-thyroid-cancer-risk-factors-among-women-living-at-the-central-region-of-iran-a-casecontrol-study","Investigating papillary thyroid cancer risk factors among women living at the central region of Iran - a case–control study","","Study focusing on papillary thyroid cancer risk among women in central Iran (Yazd), using a case–control design to clarify factors not fully recognized in the region. Women diagnosed with papillary thyroid cancer formed the case group, while two distinct control groups were drawn from relatives and non-relatives between 2020 and 2022. Data covered demographics, reproductive and medical history, thyroid and non-thyroid conditions, head-and-neck radiation exposure, and familial cancer history. Binary logistic regression identified OCP use and head-and-neck radiation as key risk factors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/investigating-papillary-thyroid-cancer-risk-factors-among-women-living-at-the-central-region-of-iran-a-casecontrol-study/370177/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/investigating-papillary-thyroid-cancer-risk-factors-among-women-living-at-the-central-region-of-iran-a-casecontrol-study/370177.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the aim of this study?","Question",{"text":63,"@type":64},"To investigate risk factors for thyroid cancer among women living in Yazd, at the center of Iran.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the participants and control groups selected?",{"text":68,"@type":64},"The study used a case–control design with women diagnosed with papillary thyroid cancer as cases, and two control groups drawn from relatives and non-relatives between 2020 and 2022.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were found to be risk factors in the results?",{"text":72,"@type":64},"History of OCP use and exposure to head and neck radiation remained in the model as risk factors across the case–relative, case–non-relative, and case–total control comparisons.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370177,1790497576,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Ghoshouni etal. BMC Endocrine Disorders (2025) 25:12 BMC Endocrine Disorders  \n[https://doi.org/10.1186/s12902-025-01833-3](https://doi.org/10.1186/s12902-025-01833-3)  \n RESEARCH Open Access  \nInvestigating papillary thyroid cancer risk   factors among women living at the central region of Iran: a case–control study  \nHamed Ghoshouni1, Saeed Hosseini2,3, Akram Ghadiri‑Anari4, Reyhaneh Azizi4, Masoud Rahmanian4 and Narjes Hazar4*  \nAbstract  \nBackground The etiology of thyroid cancer especially in women in not well recognized in Yazd, at the center of Iran. The aim of present study was to investigate the risk factors of thyroid cancer among women living in this province. Methods The present study was carried out as a case–control study, comprising women diagnosed with papillary thyroid cancer (PTC) as the case group, along with two distinct control groups sourced from different origins (i. e., relatives and non‑relatives) between 2020 and 2022. Data pertaining to several risk factors including demographic characteristics, reproductive variables, medical history related to thyroid and non‑thyroid ailments, exposure to head and neck radiation, as well as familial cancer history, was collected from all participants. Binary logistic regression was utilized to discover risk and protective factors.  \nResults In present study, 77 individuals participated in the case group, 76 in the relative control group and 72 in the non‑relative control group. The history of OCP use and exposure to head and neck radiation were remained in the model as risk factors in all three case‒relative control (OR = 6 . 65, 95%CI: 2.53‒17 .49; P‑value \u003C 0. 001), case‒non‑ relative control (OR = 6 . 32, 95%CI: 2.14‒18 . 70; P‑value = 0 . 001) and case‒total control comparisons (OR = 6 . 66, 95%CI: 2.84‒15. 64; P‑value \u003C 0. 001) .  \nConclusion The OCP use as well as exposure to head and neck radiation were determined to be strong or relatively strong risk factors in both case‒relative control and case‒non‑relative control comparisons. Consequently, it seems these two factors represent genuine risk factors for papillary thyroid cancer.  \nKeywords Thyroid Cancer, Papillary, Risk factors, Contraceptives, Oral, Case–control studies, Iran  \n*Correspondence:  \nNarjes Hazar [Narjeshazar@yahoo.com](Narjeshazar@yahoo.com)  \n1 Cardiovascular Epidemiology Research Center, Rajaie Cardiovascular Institute, Tehran, Iran  \n2 Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran  \n3 Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran  \n4 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nGhoshouni etal. BMC Endocrine Disorders (2025) 25:12  \nIntroduction  \nThyroid cancer is a relatively rare neoplasm worldwide, accounting for approximately 1–5% of all cancersin women and less than 2% of all cancers in men [1]. Although thyroid c","cbCaiktgflQZmOT9","https://ap.wps.com/l/cbCaiktgflQZmOT9","pdf",787436,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the aim of this study?\",\"answer\":\"To investigate risk factors for thyroid cancer among women living in Yazd, at the center of Iran.\"},{\"question\":\"How were the participants and control groups selected?\",\"answer\":\"The study used a case–control design with women diagnosed with papillary thyroid cancer as cases, and two control groups drawn from relatives and non-relatives between 2020 and 2022.\"},{\"question\":\"Which factors were found to be risk factors in the results?\",\"answer\":\"History of OCP use and exposure to head and neck radiation remained in the model as risk factors across the case–relative, case–non-relative, and case–total control comparisons.\"}]","Investigating papillary thyroid cancer risk factors among women living at the central region of Iran - a case–control study | PDF",1790187167,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d50e8b1abab0e2b77423779c17c40d2.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/095ef9bb3ea546878c80169108c810ba.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ef755ce6e4f3076905771bf94b2f690.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18d64b60d1800b2d76fca2e0098291f3.webp",980,1301]